Literature DB >> 26207446

A Corticosteroid Gene Therapy Combination Strategy to Maximize Intramuscular-Mediated Delivery in Postischemic Myocardium.

Anthony S Fargnoli1, Michael G Katz1, Michael P Alexander1, Andrew P Kendle1, Charles R Bridges1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26207446      PMCID: PMC4606034          DOI: 10.1089/humc.2015.061

Source DB:  PubMed          Journal:  Hum Gene Ther Clin Dev        ISSN: 2324-8637            Impact factor:   5.032


× No keyword cloud information.
  4 in total

1.  Incomplete retention after direct myocardial injection.

Authors:  P Michael Grossman; Zhenguo Han; Maria Palasis; James J Barry; Robert J Lederman
Journal:  Catheter Cardiovasc Interv       Date:  2002-03       Impact factor: 2.692

2.  Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.

Authors:  T K Rosengart; L Y Lee; S R Patel; T A Sanborn; M Parikh; G W Bergman; R Hachamovitch; M Szulc; P D Kligfield; P M Okin; R T Hahn; R B Devereux; M R Post; N R Hackett; T Foster; T M Grasso; M L Lesser; O W Isom; R G Crystal
Journal:  Circulation       Date:  1999-08-03       Impact factor: 29.690

3.  How to optimize in vivo gene transfer to cardiac myocytes: mechanical or pharmacological procedures?

Authors:  D Logeart; S N Hatem; M Heimburger; A Le Roux; J B Michel; J J Mercadier
Journal:  Hum Gene Ther       Date:  2001-09-01       Impact factor: 5.695

4.  An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure.

Authors:  Marc S Penn; Farrell O Mendelsohn; Gary L Schaer; Warren Sherman; Maryjane Farr; Joseph Pastore; Didier Rouy; Ruth Clemens; Rahul Aras; Douglas W Losordo
Journal:  Circ Res       Date:  2013-02-21       Impact factor: 17.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.